Contrast medium enhanced susceptibility imaging signal mechanism; should we use contrast medium?

dc.contributor.authorAydın, Ömer
dc.contributor.authorBüyükkaya, Ramazan
dc.contributor.buuauthorHakyemez, Bahattin
dc.contributor.departmentUludağ Üniversitesi/Tıp Fakültesi/Radyoloji Anabilim Dalı.tr_TR
dc.contributor.orcid0000-0002-3425-0740tr_TR
dc.contributor.researcheridAAI-2318-2021tr_TR
dc.contributor.scopusid6602527239tr_TR
dc.date.accessioned2023-01-30T11:39:48Z
dc.date.available2023-01-30T11:39:48Z
dc.date.issued2017-01-01
dc.description.abstractBackground Intracranial lesions exhibit clear contrast enhancement in T1-weighted imaging, but the mechanism whereby contrast-enhanced susceptibility-weighted imaging (CE-SWI) generates signals remains unclear. Contrast enhancement patterns cannot be reliably predicted. Purpose To explore the mechanism of CE-SWI contrast enhancement. Material and Methods Fifty-five patients were retrospectively enrolled. All of the imaging employed a clinical 3T magnetic resonance imaging (MRI) system fitted with a 32-channel head coil. Minimum-intensity projection reformatted images were evaluated. Intracranial lesions and brain parenchymal intensities were explored using SWI and CE-SWI. signal intensity rates were calculated by dividing the lesional intensity by the white matter intensity, after which the SWI and CE-SWI signal intensity rate were compared. Two observers independently performed intralesional susceptibility signal analysis. Results After contrast medium administration, malignant and extra-axial tumors exhibited obvious contrast enhancement on CE-SWI (P<0.001 and P=0.013, respectively). The signal intensity of white matter was significantly reduced. The signal intensity rates rose significantly in the benign, malignant, and extra-axial groups (P<0.001). Between-radiologist agreement in terms of intralesional susceptibility signal assessment was strong (kappa=0.8, P<0.001). Conclusion Contrast media can either reduce or increase SWI signal intensities. The dual contrast feature of CE-SWI can be useful when exploring intracranial disorders.en_US
dc.identifier.citationAydın, Ö. vd. (2017). ''Contrast medium enhanced susceptibility imaging signal mechanism; should we use contrast medium?''. Acta Radiologica, 58(1), 107-113.en_US
dc.identifier.endpage113tr_TR
dc.identifier.issn0284-1851
dc.identifier.issue1tr_TR
dc.identifier.pubmed26966145tr_TR
dc.identifier.scopus2-s2.0-85006483742tr_TR
dc.identifier.startpage107tr_TR
dc.identifier.urihttps://doi.org/10.1177/0284185116637246
dc.identifier.uri1600-0455
dc.identifier.urihttps://journals.sagepub.com/doi/10.1177/0284185116637246
dc.identifier.urihttp://hdl.handle.net/11452/30713
dc.identifier.volume58tr_TR
dc.identifier.wos000390557900015tr_TR
dc.indexed.pubmedPubMeden_US
dc.indexed.scopusScopusen_US
dc.indexed.wosSCIEen_US
dc.language.isoenen_US
dc.publisherSage Puplicationsen_US
dc.relation.collaborationYurt içitr_TR
dc.relation.collaborationSanayitr_TR
dc.relation.journalActa Radiologicaen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergitr_TR
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectRadiology, nuclear medicine & medical imagingen_US
dc.subjectContrast mediumen_US
dc.subjectSusceptibility weighted imagingen_US
dc.subjectBlood brain barrieren_US
dc.subjectAngiogenesisen_US
dc.subjectTumoren_US
dc.subjectHigh-resolutionen_US
dc.subjectRadiation necrosisen_US
dc.subjectGrade gliomasen_US
dc.subjectBrainen_US
dc.subjectDifferentiationen_US
dc.subjectPatternsen_US
dc.subjectMagnetic resonance imagingen_US
dc.subjectTissueen_US
dc.subjectTumorsen_US
dc.subjectAngiogenesisen_US
dc.subjectBlood-brain barrieren_US
dc.subjectContrast enhancementen_US
dc.subjectContrast mediumen_US
dc.subjectContrast-enhanceden_US
dc.subjectSignal intensitiesen_US
dc.subjectSusceptibility weighted Imagingen_US
dc.subjectWhite matteren_US
dc.subjectContrast mediaen_US
dc.subject.emtreeGadoterate meglumineen_US
dc.subject.emtreeContrast mediumen_US
dc.subject.emtreeGadoterate meglumineen_US
dc.subject.emtreeMeglumineen_US
dc.subject.emtreeOrganometallic compounden_US
dc.subject.emtreeAdolescenten_US
dc.subject.emtreeAgeden_US
dc.subject.emtreeArticleen_US
dc.subject.emtreeBenign neoplasmen_US
dc.subject.emtreeBrain canceren_US
dc.subject.emtreeBrain damageen_US
dc.subject.emtreeBrain tissueen_US
dc.subject.emtreeChilden_US
dc.subject.emtreeContrast enhancementen_US
dc.subject.emtreeControlled studyen_US
dc.subject.emtreeFemaleen_US
dc.subject.emtreeHumanen_US
dc.subject.emtreeImage analysisen_US
dc.subject.emtreeImage displayen_US
dc.subject.emtreeImage processingen_US
dc.subject.emtreeIntermethod comparisonen_US
dc.subject.emtreeInterrater reliabilityen_US
dc.subject.emtreeIntracranial tumoren_US
dc.subject.emtreeMajor clinical studyen_US
dc.subject.emtreeMaleen_US
dc.subject.emtreeNuclear magnetic resonance scanneren_US
dc.subject.emtreeParenchymaen_US
dc.subject.emtreePriority journalen_US
dc.subject.emtreeRetrospective studyen_US
dc.subject.emtreeSignal detectionen_US
dc.subject.emtreeSusceptibility weighted imagingen_US
dc.subject.emtreeWhite matteren_US
dc.subject.emtreeAdulten_US
dc.subject.emtreeBrain tumoren_US
dc.subject.emtreeComplicationen_US
dc.subject.emtreeComputer assisted diagnosisen_US
dc.subject.emtreeDiagnostic imagingen_US
dc.subject.emtreeImage enhancementen_US
dc.subject.emtreeMagnetic resonance angiographyen_US
dc.subject.emtreeMiddle ageden_US
dc.subject.emtreeNeovascularization (pathology)en_US
dc.subject.emtreePreschool childen_US
dc.subject.emtreeProceduresen_US
dc.subject.emtreeReproducibilityen_US
dc.subject.emtreeSensitivity and specificityen_US
dc.subject.emtreeYoung adulten_US
dc.subject.meshAdolescenten_US
dc.subject.meshAdulten_US
dc.subject.meshAgeden_US
dc.subject.meshBrain neoplasmsen_US
dc.subject.meshChilden_US
dc.subject.meshChild, preschoolen_US
dc.subject.meshContrast mediaen_US
dc.subject.meshFemaleen_US
dc.subject.meshHumansen_US
dc.subject.meshImage enhancementen_US
dc.subject.meshImage interpretation, computer-assisteden_US
dc.subject.meshMagnetic resonance angiographyen_US
dc.subject.meshMaleen_US
dc.subject.meshMeglumineen_US
dc.subject.meshMiddle ageden_US
dc.subject.meshNeovascularization, pathologicen_US
dc.subject.meshOrganometallic compoundsen_US
dc.subject.meshReproducibility of resultsen_US
dc.subject.meshSensitivity and specificityen_US
dc.subject.meshYoung adulten_US
dc.subject.scopusSubstantia Nigra; Susceptibility; Pulvinaren_US
dc.subject.wosRadiology, nuclear medicine & medical imagingen_US
dc.titleContrast medium enhanced susceptibility imaging signal mechanism; should we use contrast medium?en_US
dc.typeArticle
dc.wos.quartileQ3en_US

Files

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: